New Jersey Assembly Bill AJR181

New Jersey 2022-2023 Regular Session

• Introduced: 9/22/22
• Refer: 9/22/22

Caption

Designates October of each year as "Eczema Awareness Month" in New Jersey.

Impact

The designation of Eczema Awareness Month has the potential to influence state laws by encouraging state officials and citizens to engage in educational outreach and public awareness activities focused on eczema. The resolution suggests that public officials will be prompted to help mitigate the stigma associated with eczema and promote better understanding of its symptoms and treatment options. This increased awareness could lead to enhanced support for research funding and initiatives that seek to improve care for those affected.

Summary

Assembly Joint Resolution 181 (AJR181) aims to designate October of each year as 'Eczema Awareness Month' in New Jersey. This initiative seeks to raise public awareness and understanding of eczema, a group of conditions that cause the skin to become inflamed, red, and itchy. AJR181 emphasizes the importance of recognizing the impacts of eczema, which affects an estimated 32 million Americans, with over 13 percent prevalence in New Jersey. By highlighting this month, the resolution aims to foster a supportive community for individuals living with eczema and to address misconceptions about the condition.

Contention

While AJR181 appears to be largely supportive and non-controversial, any potential contention might arise around funding for awareness activities and the prioritization of eczema in relation to other public health concerns. The resolution also indirectly touches on broader health policy issues, including the need for mental health support for those affected by visible skin conditions, which could invoke discussions about resource allocation in state healthcare programs. However, as it stands, the bill mainly focuses on awareness and support rather than proposing new regulations or changes to existing laws.